🔍 Advertising Regulation in Japan (Promotional Material Review) and Artificial Intelligence JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and the Pharmaceutical Industry — Weekly 2026-W39

Weekly Aggregate2026-09-21 – 2026-09-21 · 3 items

This page is a mechanical aggregation of the daily data and carries no commentary. See the daily pages for interpretation.

💰 Investment MapAmounts are extracted from source text by pattern matching only. No currency conversion.
AmountDealFunctionSource
US$290mByteDance spin-off Anew Labs raises US$290m as AI drug developers enjoy fundraising boom🏛️ Enterprise AI Platform & GovernanceThe Star
$98.5MWhat Is Tempus AI (TEM)? The $98.5M Mark Behind Q2🏛️ Enterprise AI Platform & GovernancePhemex
$20MMithrl Raises $20M to Scale Its Biopharma AI Infrastructure🏛️ Enterprise AI Platform & GovernanceWowtale
🧬 Drug Discovery0
No items today · See past 90 days →
🧪 Clinical Development0
No items today · See past 90 days →
📑 CTD / Regulatory Submission0
No items today · See past 90 days →
🩺 GCP Operations0
No items today · See past 90 days →
📘 ICH Guidelines & AI0
No items today · See past 90 days →
🛡️ Pharmacovigilance / GVP0
No items today · See past 90 days →
📊 RWE / Evidence Generation0
No items today · See past 90 days →
🎓 Medical Affairs0
No items today · See past 90 days →
💼 Sales0
No items today · See past 90 days →
📣 Marketing0
No items today · See past 90 days →
🚚 Distribution / Supply Chain0
No items today · See past 90 days →
GQP / Quality Assurance0
No items today · See past 90 days →
👥 Human Resources0
No items today · See past 90 days →
💴 Finance & Accounting0
No items today · See past 90 days →
🏛️ Enterprise AI Platform & Governance3
← Weekly Index